Clearmind Advances CMND-100 Clinical Program with Third Cohort Enrollment in Phase I/IIa AUD Trial

Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and developm...

March 13, 2026 | Friday | News
dsm-firmenich Completes $10 Million Modernization of Schenectady Premix Facility

dsm-firmenich, innovators in nutrition, health, and beauty, has announced the completion of a planned $10 million modernization program on its Schenectad...

March 12, 2026 | Thursday | News
SteinCares and Shilpa Biologicals Partner to Commercialize Biosimilar Across Latin America

New partnership combines Shilpa Biologicals’ development and manufacturing capabilities with SteinCares’ regional commercialization platform ...

March 12, 2026 | Thursday | News
Precision Endocrine Therapy: Dr. Steven Quay on Advancing (Z)-Endoxifen and Rethinking Hormone-Driven Cancer Treatment

In this BioPharma Boardroom interview, Steven Quay, Founder and CEO of Atossa Therapeutics, outlines the scientific rationale behind developing (Z)-endoxif...

March 11, 2026 | Wednesday | Expert Opinion
CMIC Co., Ltd. Partners with Bluenote to Deploy Agentic AI Across Clinical Development

CMIC Co., Ltd., a contract research organization (CRO) jointly owned by Blackstone and CMIC HOLDINGS Co. Ltd.,  announced a strategic partnership with...

March 11, 2026 | Wednesday | News
Medisolv Acquires Lilac Software to Expand AI-Driven Quality Intelligence for Value-Based Care

Collaboration brings together clinical and claims-based quality intelligence with agentic AI to help healthcare organizations close care gaps and succeed...

March 11, 2026 | Wednesday | News
Incyte Secures EU Approval for Zynyz Combination Therapy in Advanced Anal Cancer

- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult pati...

March 10, 2026 | Tuesday | News
Daiichi Sankyo and AstraZeneca Secure FDA Priority Review for Enhertu in HER2-Positive Early Breast Cancer

Daiichi Sankyo (TSE: 4568) and AstraZeneca’s (LSE/STO/NYSE: AZN) supplemental Biologics License Application (sBLA) for ENHERTU® (fam-trastuzuma...

March 10, 2026 | Tuesday | News
GenSight Biologics Advances Early Access Programs for LUMEVOQ Gene Therapy in Rare Vision Disorder

GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene...

March 10, 2026 | Tuesday | News
Agilent Technologies to Acquire Biocare Medical for $950 Million to Strengthen Global Pathology Portfolio

Expands Agilent’s pathology portfolio through addition of highly complementary antibody, reagent and instrument business with annual double-digit...

March 10, 2026 | Tuesday | News
Halozyme Therapeutics, Inc and Johnson & Johnson Secure FDA Approval for TECVAYLI® Plus DARZALEX FASPRO® in RRMM

Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme) announced that Johnson & Johnson has received approval from the U.S. Food and Drug Administrati...

March 09, 2026 | Monday | News
Eli Lilly and Company Partners with WHO Foundation to Strengthen Global Obesity Care

The WHO Foundation announced a collaboration with Eli Lilly and Company that aims to support the WHO Foundation's global efforts to assess and strengthen...

March 09, 2026 | Monday | News
Lonza Group AG Selects Hyderabad for Global Capability Centre, Expanding Presence in India

Lonza Group AG, a world-leading contract development and manufacturing organisation (CDMO), has announced its decision to establish a new Global Capability...

March 09, 2026 | Monday | News
UK Investment Zones Expand to Scotland to Accelerate Life Sciences Innovation

Two Investment Zones designated in Scotland to establish UK-wide Investment Zones network. Investment Zones with designated tax sites offer tax benefits...

March 09, 2026 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close